cedure consisted of clinical examination and histological examination. The cumulative five year survival was 17°for all small cell lung cancer, and 350O and 23oo for stage I and II small cell lung cancer respectively. Limited stage disease was treated by surgery alone. For these patients distant metastases accounted for relapses. The authors concluded that surgery offers survival benefit in limited stage disease. Many phase II studies of surgical management in small cell lung cancer have shown similar results (for review see ref 1).
Recent studies suggest that metastatic disease is underevaluated in small cell lung cancer. By means of magnetic resonance imaging it has been shown that halfofall cases of so called limited stage disease in small cell lung cancer according to routine staging procedures have bone marrow disease.2 In our institution we have observed in many instances early metastatic relapses in patients with small cell lung cancer after surgery alone (figure). Thus chemotherapy remains the first line treatment for small cell lung cancer because of early metastatic spread and we prefer to avoid lung cancer surgery before histological classification.
In phase II studies of surgery for limited stage disease long term survival may be due only to a selection bias of patients with good prognosis. To assess the survival benefit obtained by surgery phase III trials comparing chemotherapy with and without surgery are needed.' Moreover, neoadjuvant chemotherapy in small cell lung cancer may treat the microscopic metastatic disease. Surgery following neoadjuvant chemotherapy may resect chemoresistant tumour remainders and it offers the opportunity to study the biology of small cell lung cancer Cream's original series of Henoch-Schonlein purpura in adults contains many patients who would now be classified as having microscopic polyarteritis.3 The distinction between the two is of practical importance. There is growing evidence that substantial recovery of renal function can be obtained in patients with microscopic polyarteritis with the use of aggressive immunosuppressive treatment.4 The discovery of antineutrophil cytoplasmic antibodies (ANCA) in virtually all patients with microscopic polyarteritis means that for the first time there is a non-invasive sensitive test with a high specificity capable of distinguishing between these two disorders.5 More widespread use of ANCA in patients with cutaneous vasculitis and deep organ lesions, we may hope, will assist physicians in the diagnosis and management of these conditions in future.
D VEALE M C VENNING A QUINN The clinical features of our case are those described in classical Henoch-Schonlein purpura: namely, arthralgia, gastrointestinal haemorrhage, glomerulonephritis, and the characteristic rash affecting the buttocks and extensor surfaces of the lower limbs. Since reading their letter we have restained sections of the original renal tissue, using improved immunofluorescence techniques; the glomeruli show no IgG but IgA and IgM are present in the glomerular tufts. There is also, however, some intraepithelial tubular staining, suggesting that at least some of the glomerular staining may be due to a prefixation diffusion artefact; immunoglobulins may enter cells by passive diffusion if fixation is not prompt. The necropsy in this case was carried out on the fifth day after death. Thus we are reluctant to attach too much significance to the immunofluorescence findings.
The ANCA test does offer exciting possibilities in the non-invasive diagnosis and classification of the arthritides, though our patient presented in 1984 before it was available. A recent study, however, has suggested that it may not be quite as specific or sensitive for microscopic polyarteritis as suggested by Savage et al.' Using an indirect immunofluorescence assay, Harrison et al found the granular pattern of cytoplasmc staining to be highly specific for Wegener's granulo-matosis2; but the diffuse pattern of staining usually reported in microscopic polyarteritis was less specific or sensitive for microscopic polyarteritis: seven of 12 cases showed weak or insignificant staining, whereas strongly positive diffuse staining was seen in cases of polymyalgia rheumatica and Paget's disease. Savage et al did use a combination of an immunofluorescence assay and radioimmunoassay, but the very high sensitivity and specificity they reported in microscopic polyarteritis needs confirmation; if it is confirmed both assays need to be available for firm clinical decisions to be based on the result. 
